NorthX Biologics
Ola Tuvesson is currently a Board Member at AdBIOPRO, where he is focused on developing and intensifying bio-processes to make advanced therapies more accessible. Previously, he served as the Chief Technology Officer at NorthX Biologics, where he led development and project organization. He also held roles at Cobra Biologics and Unitech BioPharma, gaining experience in process development and production within the biopharmaceutical industry. Ola has a Master of Science degree in Engineering Biotechnology from Linköping University.